NAD attenuates oxidative DNA damages induced by amyloid beta-peptide in primary rat cortical neurons

Free Radical Research

Volumn 48, Issue 7, 2014, Pages 794-805

  Wu, M F ^a   Yin, J H ^b   Hwang, C S ^a,c   Tang, C M ^a   Yang, D I ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

8 hydroxy 2 deoxyguanosine; Alzheimer's disease; Amyloid beta; DNA oxidation; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; GENOMIC DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE; REACTIVE OXYGEN METABOLITE; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); AMYLOID BETA-PROTEIN (25-35); DNA; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; APURINIC SITE; APYRIMIDINIC SITE; ARTICLE; ASTROCYTE; BRAIN CELL; BRAIN CELL CULTURE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DOUBLE STRANDED DNA BREAK; DRUG CYTOTOXICITY; FETUS; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; SINGLE STRANDED DNA BREAK; ANIMAL; BRAIN CORTEX; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; INBRED MOUSE STRAIN; ISOLATION AND PURIFICATION; METABOLISM; NERVE CELL; OXIDATION REDUCTION REACTION; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

AMYLOID BETA-PEPTIDES; ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; DNA; DNA DAMAGE; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; NAD; NEURONS; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 84902186016     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2014.907889     Document Type: Article

References (31)

1. O'Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 2011; 34: 185-204.
2. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994; 77: 817-827.
3. Santos RX, Correia SC, Zhu X, Lee HG, Petersen RB, Nunomura A, et al. Nuclear and mitochondrial DNA oxidation in Alzheimer's disease. Free Radic Res 2012; 46: 565-576.
4. Lovell MA, Gabbita SP, Markesbery WR. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J Neurochem 1999; 72: 771-776.
5. Lovell MA, Soman S, Bradley MA. Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mech Ageing Dev 2011; 132: 443-448.
6. Wang J, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem 2006; 96: 825-832.
7. Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 2005; 93: 953-962.
8. Ying W. NAD- and NADH in cellular functions and cell death. Front Biosci 2006; 11: 3129-3148.
9. Ying W. NAD- /NADH and NADP- /NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 2008; 10: 179-206.
10. Abeti R, Duchen MR. Activation of PARP by oxidative stress induced by beta-amyloid: implications for Alzheimer's disease. Neurochem Res 2012; 37: 2589-2596.
11. Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 2006; 281: 21745-21754.
12. Chen SD, Wu CL, Lin TK, Chuang YC, Yang DI. Renin inhibitor aliskiren exerts neuroprotection against amyloid beta-peptide toxicity in rat cortical neurons. Neurochem Int 2012; 61: 369-377.
13. Wu CL, Yin JH, Hwang CS, Chen SD, Yang DY, Yang DI. c-Jun-dependent sulfiredoxin induction mediates BDNF protection against mitochondrial inhibition in rat cortical neurons. Neurobiol Dis 2012; 46: 450-462.
14. Wu CL, Hwang CS, Yang DI. Protective effects of brain-derived neurotrophic factor against neurotoxicity of 3-nitropropionic acid in rat cortical neurons. Neurotoxicology 2009; 30: 718-726.
15. Wu CL, Chen SD, Yin JH, Hwang CS, Yang DI. Erythropoietin and sonic hedgehog mediate the neuroprotective effects of brain-derived neurotrophic factor against mitochondrial inhibition. Neurobiol Dis 2010; 40: 146-154.
16. Chen J, Jin K, Chen M, Pei W, Kawaguchi K, Greenberg DA, Simon RP. Early detection of DNA strand breaks in the brain after transient focal ischemia: implications for the role of DNA damage in apoptosis and neuronal cell death. J Neurochem 1997; 69: 232-245.
17. Tang CM, Hwang CS, Chen SD, Yang DI. Neuroprotective mechanisms of minocycline against sphingomyelinase/ceramide toxicity: roles of Bcl-2 and thioredoxin. Free Radic Biol Med 2011; 50: 710-721.
18. Ju TC, Yang YT, Yang DI. Protective effects of S-nitrosoglutathione against neurotoxicity of 3-nitropropionic acid in rat. Neurosci Lett 2004; 362: 226-231.
19. Moreira PI, Nunomura A, Nakamura M, Takeda A, Shenk JC, Aliev G, et al. Nucleic acid oxidation in Alzheimer disease. Free Radic Biol Med 2008; 44: 1493-1505.
20. Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 1984; 12: 2137-2145.
21. Dizdaroglu M. Base-excision repair of oxidative DNA damage by DNA glycosylases. Mutat Res 2005; 591: 45-59.
22. Clark RSB, Chen M, Kochanek PM, Watkins SC, Jin KL, Draviam R, et al. Detection of single- and double-strand DNA breaks after traumatic brain injury in rats: comparison of in situ labeling techniques using DNA polymerase I, the Klenow fragment of DNA polymerase I, and terminal deoxynucleotidyl transferase. J Neurotrauma 2001; 18: 675-689.
23. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, et al. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 2006; 24: 516-524.
24. Wang S, Xing Z, Vosler PS, Yin H, Li W, Zhang F, et al. Cellular NAD replenishment confers marked neuroprotection against ischemic cell death: role of enhanced DNA repair. Stroke 2008; 39: 2587-2595.
25. Wang J, Zhai Q, Chen Y, Lin E, Gu W, McBurney MW, He Z. A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol 2005; 170: 349-355.
26. Pittelli M, Felici R, Pitozzi V, Giovannelli L, Bigagli E, Cialdai F, et al. Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis. Mol Pharmacol 2011; 80: 1136-1146.
27. Kim TK, Lee JE, Park SK, Lee KW, Seo JS, Im JY, et al. Analysis of differential plaque depositions in the brains of Tg2576 and Tg-APPswe/PS1dE9 transgenic mouse models of Alzheimer disease. Exp Mol Med 2012; 44: 492-502.
28. Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, et al. Episodic-like memory deficits in the APPswe/ PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis 2005; 18: 602-617.
29. Reiserer RS, Harrison FE, Syverud DC, McDonald MP. Impaired spatial learning in the APPSwe - PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. Genes Brain Behav 2007; 6: 54-65.
30. Xiong H, Callaghan D, Wodzinska J, Xu J, Premyslova M, Liu QY, et al. Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease. Neurosci Bull 2011; 27: 221-232.
31. Gong B, Pan Y, Vempati P, Zhao W, Knable L, Ho L, et al. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor- γ coactivator 1 α regulated beta-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Neurobiol Aging 2013; 34: 1581-1588.